APA (7th ed.) Citation

S, S., E, F., P, P., F, L., H, L., A, H., . . . F, A. (2025). Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID. The Journal of infection, 90(1), 106376. https://doi.org/10.1016/j.jinf.2024.106376

Chicago Style (17th ed.) Citation

S, Soueges, et al. "Real-world Multicentre Study of Cefiderocol Treatment of Immunocompromised Patients with Infections Caused by Multidrug-resistant Gram-negative Bacteria: CEFI-ID." The Journal of Infection 90, no. 1 (2025): 106376. https://doi.org/10.1016/j.jinf.2024.106376.

MLA (9th ed.) Citation

S, Soueges, et al. "Real-world Multicentre Study of Cefiderocol Treatment of Immunocompromised Patients with Infections Caused by Multidrug-resistant Gram-negative Bacteria: CEFI-ID." The Journal of Infection, vol. 90, no. 1, 2025, p. 106376, https://doi.org/10.1016/j.jinf.2024.106376.